BCYC
Bicycle Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$3.72
+1.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 46.96x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.52x
- Price / sales
- 3.12x
- Price / cash flow
- -1.49x
Enterprise value
- Enterprise value
- -$196.7M
- EV / sales
- -2.35x
- EV / EBITDA
- 1.46x
- EV / EBIT
- 1.24x
- Market cap
- $260.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026